WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 6 fonti

GLP-1s demonstrate ‘large’ & ‘consistent’ protective effects against cancer metastases

CHICAGO — GLP-1 receptor agonists may help mitigate progression of at least some obesity-related cancers, according to retrospective study results presented at ASCO Annual Meeting.A database analysis of individuals diagnosed with stage I to stage III cancers showed those who used GLP-1 medications had lower risk for developing metastatic disease than those who used dipeptidyl peptidase-4

Raccontata dahealio.commedpagetoday.comlastampa.itnbcnews.comindependent.co.ukhuffpost.com

Confronto fonti

6 prospettive sulla stessa storia
AI · summaries
healio.comStai leggendo1 mesi fa

GLP-1s demonstrate ‘large’ & ‘consistent’ protective effects against cancer metastases

CHICAGO — GLP-1 receptor agonists may help mitigate progression of at least some obesity-related cancers, according to retrospective study results presented at ASCO Annual Meeting.A database analysis of individuals…

originale

Timeline cronologica

  1. martedì 19 maggio 2026·healio.com

    GLP-1s show no significant link with diabetic retinopathy progression

    Data collected from a number of clinical trials found that despite recent “buzz,” there is no significant link between GLP-1 receptor agonists and the progression of diabetic…

  2. giovedì 21 maggio 2026·healio.com

    GLP-1s demonstrate ‘large’ & ‘consistent’ protective effects against cancer metastases

    CHICAGO — GLP-1 receptor agonists may help mitigate progression of at least some obesity-related cancers, according to retrospective study results presented at ASCO Annual…

medpagetoday.com
1 mesi fa

GLP-1s Linked to Lower Risk of Cancer Spread in Four Tumor Types

Accumulating evidence of possible benefit warrants randomized trials, experts say

Leggi questa versione → originale
huffpost.com1 mesi fa

GLP-1 Users May Experience A Surprising Lifesaving Benefit That Has Nothing To Do With Weight Loss

A new study found that some cancer patients who took GLP-1 drugs saw some remission — especially if they had breast cancer.

Leggi questa versione → originale
nbcnews.com1 mesi fa

GLP-1 drugs may reduce the risk of cancer progressing, study suggests

Research from the Cleveland Clinic found that people who started a GLP-1 drug after their diagnosis were less likely to progress to stage 4.

Leggi questa versione → originale
independent.co.uk1 mesi fa

GLP-1 drugs may result in better outcomes for cancer patients, study claims

GLP-1 drugs, such as Ozempic and Wegovy, may slow down the spread of obesity-related cancers, according to researchers

Leggi questa versione → originale
lastampa.it1 mesi fa

I farmaci anti-obesità potrebbero ridurre il rischio di metastasi in quattro tumori

Gli analoghi di Glp-1 sembrano prevenire la progressione delle neoplasie verso lo stadio metastatico nei pazienti diabetici. Lo rivela uno studio presentato du…

Leggi questa versione → originale
  • giovedì 21 maggio 2026·medpagetoday.com

    GLP-1s Linked to Lower Risk of Cancer Spread in Four Tumor Types

    Accumulating evidence of possible benefit warrants randomized trials, experts say

  • giovedì 21 maggio 2026·lastampa.it

    I farmaci anti-obesità potrebbero ridurre il rischio di metastasi in quattro tumori

    Gli analoghi di Glp-1 sembrano prevenire la progressione delle neoplasie verso lo stadio metastatico nei pazienti diabetici. Lo rivela uno studio presentato du…

  • giovedì 21 maggio 2026·nbcnews.com

    GLP-1 drugs may reduce the risk of cancer progressing, study suggests

    Research from the Cleveland Clinic found that people who started a GLP-1 drug after their diagnosis were less likely to progress to stage 4.

  • venerdì 22 maggio 2026·independent.co.uk

    GLP-1 drugs may result in better outcomes for cancer patients, study claims

    GLP-1 drugs, such as Ozempic and Wegovy, may slow down the spread of obesity-related cancers, according to researchers

  • sabato 23 maggio 2026·huffpost.com

    GLP-1 Users May Experience A Surprising Lifesaving Benefit That Has Nothing To Do With Weight Loss

    A new study found that some cancer patients who took GLP-1 drugs saw some remission — especially if they had breast cancer.